FDA approves first new antibiotic for UTIs in nearly 30 years
The FDA approved a new antibiotic for UTIs from drugmaker GSK. The drug, Blujepa, is for women and girls ages 12 and up.
FDA approves a new kind of oral antibiotic to treat urinary tract infections
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
US FDA approves GSK's urinary tract infection drug
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
The American Journal of Managed Care1h
FDA Approves First New Class of Oral Antibiotics for Uncomplicated UTIs in Nearly 30 Years
The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...
Fierce Pharma2h
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...